Scientists discovered a special type of beneficial bacteria called Lactiplantibacillus plantarum GX17 that could help animals stay healthy. This bacteria was found in the guts of healthy chickens and appears to be tough enough to survive harsh conditions like heat, cold, and stomach acid. Researchers studied the bacteria’s genetic makeup and tested how it behaves under stress. The results suggest this bacteria has strong protective qualities and could potentially be used as a natural supplement in animal feed to improve digestion, boost immunity, and reduce the need for antibiotics. While the findings are promising, more research is needed to confirm these benefits in real-world situations.
The Quick Take
- What they studied: Whether a newly discovered beneficial bacteria strain could work as a natural health supplement for animals by examining its genetic code and how it survives tough conditions
- Who participated: Researchers isolated bacteria from the intestines of healthy chickens and studied it in laboratory conditions; no human or animal feeding trials were conducted in this study
- Key finding: The bacteria strain GX17 contains 50 genes that help it resist stress and showed strong survival abilities when exposed to heat, cold, acid, salt, and simulated stomach conditions
- What it means for you: This bacteria may eventually help farm animals digest food better and stay healthier without antibiotics, though more testing in actual animals and humans is needed before it can be used as a supplement
The Research Details
Scientists took a multi-step approach to understand this bacteria. First, they extracted the complete genetic blueprint (genome) of the bacteria strain and identified all the genes it contains—finding about 1,771 different genes. They specifically looked for genes related to stress survival and potential harmful factors. Second, they performed laboratory experiments to test how well the bacteria could survive challenging conditions like extreme temperatures, acidic environments (like stomach acid), salty conditions, and alkaline (basic) environments. Third, they used advanced technology to measure which genes were turned on or off when the bacteria faced stress. This three-part approach—genetic analysis, physical testing, and gene activity monitoring—allowed researchers to confirm that what the bacteria’s genes suggested matched what actually happened when tested.
This research approach is important because it connects the bacteria’s genetic potential to its actual performance. Just because a bacteria has genes for survival doesn’t guarantee it will actually survive in real conditions. By confirming that the genes matched the actual behavior, researchers could confidently say this bacteria strain is genuinely tough and reliable as a potential probiotic candidate.
This study is a foundational laboratory investigation that identifies a promising bacteria candidate. The genetic analysis is thorough and the stress-resistance testing is comprehensive. However, this research was conducted entirely in laboratory conditions using isolated bacteria—not in living animals or humans. The study does not include feeding trials, safety testing in animals, or human clinical trials. These limitations mean the findings are promising but preliminary. Before this bacteria could be used in animal feed or human supplements, additional studies testing it in actual animals and humans would be necessary.
What the Results Show
The bacteria strain GX17 has a complete genetic code of approximately 29.5 million base pairs (the building blocks of DNA) containing about 1,771 genes. Researchers identified 50 specific genes designed to help the bacteria resist stress—these are like survival tools in the bacteria’s toolkit. The laboratory tests confirmed the bacteria is genuinely tough: it survived high temperatures (heat resistance), low temperatures (cold resistance), very acidic conditions (like stomach acid), very basic conditions (alkaline resistance), and salty environments. The bacteria also showed strong antioxidant capacity, meaning it can neutralize harmful molecules that damage cells. When researchers measured gene activity under stressful conditions, they found that key survival genes were turned up significantly—the bacteria was actively using its protective tools when needed.
The analysis identified seven virulence factors in the bacteria’s genome. Virulence factors are genes that could potentially cause harm, but their presence alone doesn’t mean the bacteria is dangerous—many beneficial bacteria carry these genes without causing problems. The bacteria’s ability to survive artificial gastrointestinal fluid (a laboratory simulation of stomach and intestinal conditions) was particularly strong, suggesting it could potentially survive passage through an animal’s digestive system. The strong antioxidant capacity is significant because oxidative stress damages cells and contributes to inflammation and disease.
Lactobacilli bacteria have been studied for decades and are well-known as beneficial microorganisms. This particular strain (GX17) appears to have stronger stress-resistance characteristics than many previously studied strains, based on the number of identified survival genes and the comprehensive testing results. The findings align with existing knowledge that lactobacilli can help regulate gut bacteria balance, support immune function, and improve nutrient absorption. However, this specific strain’s superior stress resistance suggests it may be more stable and effective than some alternatives currently used in animal feed.
This study has several important limitations. First, all testing was done in laboratory conditions with isolated bacteria—not in living animals or humans. Second, the study did not test whether the bacteria actually provides health benefits when consumed; it only confirmed the bacteria can survive harsh conditions. Third, no feeding trials were conducted to measure real-world effects like improved digestion, better growth rates, or reduced disease in animals. Fourth, the study did not test safety or potential side effects in animals or humans. Fifth, the presence of virulence factors, while not necessarily problematic, was not fully evaluated for safety implications. Finally, the study did not compare this strain directly to other probiotic strains currently used in animal feed.
The Bottom Line
Based on this laboratory research, the bacteria strain GX17 appears to be a promising candidate for further development as a probiotic for animal feed. However, current evidence supports only continued research—not yet practical use. The next steps should include: (1) feeding trials in chickens and other livestock to measure actual health benefits, (2) safety testing to confirm the bacteria doesn’t cause harm, (3) comparison studies with existing probiotic strains, and (4) eventual human safety and efficacy studies if human applications are planned. Confidence level: Moderate for the bacteria’s stress-resistance properties; Low for actual health benefits until animal trials are completed.
This research is most relevant to: livestock producers and feed manufacturers interested in natural alternatives to antibiotics, veterinarians looking for probiotic options, and researchers developing animal health products. It’s less immediately relevant to individual pet owners or people considering probiotics for themselves, since the research is preliminary and focused on animal applications. Anyone considering using this bacteria as a supplement should wait for completed animal and human safety studies.
If this bacteria moves forward to animal feeding trials, it would likely take 1-2 years to generate meaningful data on health benefits in livestock. Human safety and efficacy studies, if pursued, would require an additional 2-5 years. Realistic timeline for commercial availability: 3-7 years minimum, assuming positive results in upcoming trials.
Want to Apply This Research?
- For users with livestock or pets: Track weekly health metrics including feed consumption, weight gain, digestive health (stool quality), and illness frequency. If this probiotic becomes available, measure changes in these metrics over 4-week periods to assess individual animal response.
- Once this probiotic is commercially available and recommended by a veterinarian: Implement consistent daily supplementation in animal feed at the recommended dose, maintain detailed records of animal health changes, and report observations to your veterinarian to contribute to real-world effectiveness data.
- Establish a baseline of current animal health metrics (weight, feed efficiency, disease incidence) before introducing any new probiotic. After introduction, monitor the same metrics monthly for at least 3 months to assess whether the probiotic produces measurable improvements. Track any adverse reactions or unexpected changes. Share results with your veterinarian to help build evidence for this strain’s effectiveness.
This research describes laboratory findings about a bacteria strain’s genetic and stress-resistance properties. It does not demonstrate that this bacteria provides health benefits in living animals or humans. This study was not a clinical trial and did not test safety or efficacy in real-world conditions. Before using any probiotic product based on this strain, consult with a veterinarian (for animals) or healthcare provider (for humans). Do not use this bacteria or products containing it without professional medical or veterinary guidance. The presence of virulence factors in the bacteria’s genome requires further safety evaluation. This summary is for educational purposes only and should not be considered medical or veterinary advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.